Tejada, S. Et Al. 2022. Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.. Advances in therapy , vol.39, no.9 , 4037-4051.

Tejada, S., Martinez-Reviejo, R., Karakoc, H. N., Peña-López, Y., Manuel, O., & Rello, J., (2022). Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.. Advances in therapy , vol.39, no.9, 4037-4051.

Tejada, Sofia Et Al. "Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.," Advances in therapy , vol.39, no.9, 4037-4051, 2022

Tejada, Sofia Et Al. "Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.." Advances in therapy , vol.39, no.9, pp.4037-4051, 2022

Tejada, S. Et Al. (2022) . "Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.." Advances in therapy , vol.39, no.9, pp.4037-4051.

@article{article, author={Sofia Tejada Et Al. }, title={Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis.}, journal={Advances in therapy}, year=2022, pages={4037-4051} }